Caliber Imaging & Diagnostics (OTCPK:LCDX) - Stock Price, News & Analysis

LCDX Stock Overview

A medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. More details

LCDX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($857)

Latest financial reports are more than a year old

Shares are highly illiquid

Caliber Imaging & Diagnostics, Inc. Competitors

Motus GI Holdings

OTCPK:MOTS

US$2.9k

Lucira Health

OTCPK:LHDX.Q

US$4.2k

ThermoGenesis Holdings

OTCPK:THMO

US$7.9k

ViewRay

OTCPK:VRAY.Q

US$18.3k

Price History & Performance

Summary of all time highs, changes and price drops for Caliber Imaging & Diagnostics
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0002
52 Week Low	US$0.0001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	0%
33 Year Change	-99.00%
5 Year Change	-99.98%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	LCDX	US Medical Equipment	US Market
7D	0%	-0.03%	0.4%
1Y	0%	21.3%	32.3%

Return vs Industry: LCDX underperformed the US Medical Equipment industry which returned 21.3% over the past year.

Return vs Market: LCDX underperformed the US Market which returned 32.3% over the past year.

Price Volatility

Is LCDX's price volatile compared to industry and market?
LCDX volatility
LCDX Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	7.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: LCDX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine LCDX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1991	n/a	L. Hone	www.caliberid.com

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system.

Caliber Imaging & Diagnostics, Inc. Fundamentals Summary

How do Caliber Imaging & Diagnostics's earnings and revenue compare to its market cap?
LCDX fundamental statistics
Market cap	US$857.00
Earnings (TTM)	-US$6.25m
Revenue (TTM)	US$3.14m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is LCDX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LCDX income statement (TTM)
Revenue	US$3.14m
Cost of Revenue	US$2.65m
Gross Profit	US$486.00k
Other Expenses	US$6.74m
Earnings	-US$6.25m

Last Reported Earnings

Mar 31, 2014

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did LCDX perform over the long term?

See historical performance and comparison